RE:INFOTo me the Key Point is...
"Torion is currently in late-stage discussions to acquire a series of biological candidates as primary reagents for CoviSafe™. These molecules have demonstrated excellent sensitivity and specificity in initial feasibility studies."
I believe that once Torion acquires the "Secret Sauce" they should be able to release the Sensitivity and Specificity data (Not saying they will but I believe can't legally until it's acquired) and they will begin production of the Patient Sample devices.
The molecules have demonstrated Excellent Sensitivty and Specificity...Rob knows the minimum requirements for FDA and HC and "Excellent" far exceeds the minimum thresholds in my opinion.
Again this is only my opinion and GLTA